{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:35:21Z","timestamp":1790368521772,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.therap.2016.07.007","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T16:00:22Z","timestamp":1474041622000},"page":"327-337","source":"Crossref","is-referenced-by-count":1,"title":["Concordance entre prescriptions hospitali\u00e8res et recommandations dans le traitement de la manie"],"prefix":"10.1016","volume":"72","author":[{"given":"Edouard-Jules","family":"Laforgue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Bulteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennyfer","family":"Cholet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Victorri-Vigneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Guitteny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Mauduit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Vanelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Sauvaget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.therap.2016.07.007_bib0005","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.therap.2016.07.007_bib0010","series-title":"DSM-5","author":"American Psychiatric Association","year":"2013"},{"issue":"3","key":"10.1016\/j.therap.2016.07.007_bib0015","first-page":"194","article-title":"Troubles cognitifs chez les patients bipolaires vieillissants","volume":"174","author":"Cholet","year":"2016","journal-title":"Ann Med Psychol"},{"key":"10.1016\/j.therap.2016.07.007_bib0020","series-title":"ALD no\u00a023 \u2013\u00a0guide m\u00e9decin sur les troubles bipolaires","author":"Haute Autorit\u00e9 de sant\u00e9","year":"2009"},{"key":"10.1016\/j.therap.2016.07.007_bib0025","unstructured":"Base de donn\u00e9es publique des m\u00e9dicaments. http:\/\/base-donnees-publique.medicaments.gouv.fr\/ [Consult\u00e9 le 25\u00a0juillet 2016]."},{"issue":"4","key":"10.1016\/j.therap.2016.07.007_bib0030","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881109102919","article-title":"Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology","volume":"23","author":"Goodwin","year":"2009","journal-title":"J Psychopharmacol Oxf Engl"},{"issue":"1","key":"10.1016\/j.therap.2016.07.007_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.therap.2016.07.007_bib0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0447.2009.01383.x","article-title":"Clinical practice recommendations for bipolar disorder","volume":"439","author":"Malhi","year":"2009","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.therap.2016.07.007_bib0045","series-title":"The Management of bipolar disorder in adults, children and adolescents, in primary and secondary care","author":"National Institute for Health and Clinical Excellence","year":"2009"},{"issue":"3","key":"10.1016\/j.therap.2016.07.007_bib0050","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/15622975.2013.770551","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012\u00a0on the long-term treatment of bipolar disorder","volume":"14","author":"Grunze","year":"2013","journal-title":"World J Biol Psychiatry"},{"issue":"9799","key":"10.1016\/j.therap.2016.07.007_bib0055","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.therap.2016.07.007_bib0060","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/npp.2010.192","article-title":"Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials","volume":"36","author":"Yildiz","year":"2011","journal-title":"Neuropsychopharmacoly"},{"issue":"4","key":"10.1016\/j.therap.2016.07.007_bib0065","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.euroneuro.2010.08.001","article-title":"2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery","volume":"21","author":"Haro","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.therap.2016.07.007_bib0070","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1192\/bjp.170.3.264","article-title":"Generalisability of results from randomised drug trials. A trial on antimanic treatment","volume":"170","author":"Licht","year":"1997","journal-title":"Br J Psychiatry J Ment Sci"},{"issue":"1\u20133","key":"10.1016\/j.therap.2016.07.007_bib0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jad.2006.08.017","article-title":"Pharmacological treatment of acute mania in psychiatric in-patients between 1994\u00a0and 2004","volume":"99","author":"Wolfsperger","year":"2007","journal-title":"J Affect Disord"},{"issue":"12","key":"10.1016\/j.therap.2016.07.007_bib0080","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/cns.12017","article-title":"Combination therapy for manic phases: a critical review of a common practice","volume":"18","author":"Geoffroy","year":"2012","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"10.1016\/j.therap.2016.07.007_bib0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/appi.ajp.161.1.169","article-title":"Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients","volume":"161","author":"Zarate","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"12","key":"10.1016\/j.therap.2016.07.007_bib0090","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/archpsyc.60.12.1218","article-title":"A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.therap.2016.07.007_bib0095","series-title":"ICD-10, the ICD-10\u00a0classification of mental and behavioural disorders: diagnostic criteria for research","author":"World Health Organization","year":"1993"},{"key":"10.1016\/j.therap.2016.07.007_bib0100","series-title":"Diagnostic and statistical manual of mental disorders: DSM-IV-TR","author":"American Psychiatric Association","year":"2000"},{"issue":"2","key":"10.1016\/j.therap.2016.07.007_bib0105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jad.2011.10.015","article-title":"New treatment guidelines for acute bipolar mania: a critical review","volume":"140","author":"Nivoli","year":"2012","journal-title":"J Affect Disord"},{"issue":"6","key":"10.1016\/j.therap.2016.07.007_bib0110","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00004714-200012000-00004","article-title":"A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders","volume":"20","author":"Frye","year":"2000","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.therap.2016.07.007_bib0115","first-page":"64","article-title":"Modalit\u00e9s de surveillance des sels de lithium en psychiatrie: des guidelines \u00e0 la pratique","volume":"174","author":"Bulteau","year":"2016","journal-title":"Ann Med Psychol"},{"issue":"5","key":"10.1016\/j.therap.2016.07.007_bib0120","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.encep.2014.08.002","article-title":"Therapeutic management of bipolar disorder in France and Europe: a multinational longitudinal study (WAVE-bd)","volume":"40","author":"Bellivier","year":"2014","journal-title":"Encephale"},{"issue":"4","key":"10.1016\/j.therap.2016.07.007_bib0125","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.euroneuro.2012.05.017","article-title":"Faster onset of antimanic action with haloperidol compared to second-generation antipsychotics. A meta-analysis of randomized clinical trials in acute mania","volume":"23","author":"Goikolea","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"issue":"8","key":"10.1016\/j.therap.2016.07.007_bib0130","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.4088\/JCP.09m05026gre","article-title":"Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study","volume":"71","author":"Rosa","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.therap.2016.07.007_bib0135","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s11920-000-0069-4","article-title":"Prevalence and description of psychotic features in bipolar mania","volume":"2","author":"Dunayevich","year":"2000","journal-title":"Curr Psychiatry Rep"},{"issue":"10","key":"10.1016\/j.therap.2016.07.007_bib0140","first-page":"466","article-title":"Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders","volume":"56","author":"Keck","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.therap.2016.07.007_bib0145","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2014.00060","article-title":"Can antipsychotic agents be considered as real antimanic treatments?","author":"Bourin","year":"2014","journal-title":"Front Psychiatry"},{"issue":"6","key":"10.1016\/j.therap.2016.07.007_bib0150","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2515\/therapie\/2013054","article-title":"Prescriptions hors autorisation de mise sur le march\u00e9 en psychiatrie publique hospitali\u00e8re","volume":"68","author":"Andr\u00e9oli","year":"2013","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2016.07.007_bib0155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jad.2016.01.029","article-title":"A pilot study of a combined group and individual functional remediation program for patients with bipolar I disorder","volume":"194","author":"Zyto","year":"2016","journal-title":"J Affect Disord"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716311787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716311787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T12:04:32Z","timestamp":1554293072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716311787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0040595716311787"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2016.07.007","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}